Ovid Therapeutics Inc. [OVID] has reported fiscal Q1 loss of $1.30 billion.
On a per-share basis, the DE based company said its diluted earnings are $0.19.
The Pharmaceutical Preparations firm posted revenue of $66.20 million in this period.
Also Read: